Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Huntington's disease | R-HSA-1643685 | 0 | profenamine | 3290 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | profenamine | 3290 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | profenamine | 3290 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | profenamine | 3290 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | equilin | 223368 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | equilin | 223368 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | equilin | 223368 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | equilin | 223368 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | 3-acetylcoumarin | 15478 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | 3-acetylcoumarin | 15478 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | 3-acetylcoumarin | 15478 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | 3-acetylcoumarin | 15478 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | 3-acetylcoumarin | 15478 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | 3-acetylcoumarin | 15478 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | hymecromone | 72894 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | hymecromone | 72894 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | hymecromone | 72894 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | hymecromone | 72894 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | hymecromone | 72894 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | hymecromone | 72894 | drug-path |